Indicators for Monitoring National Drug Policies
(1999; 250 pages) [French] View the PDF document
Table of Contents
View the documentACKNOWLEDGEMENTS
Open this folder and view contentsCHAPTER I: Introduction
Open this folder and view contentsCHAPTER II: Development of the manual
Open this folder and view contentsCHAPTER III: Model lists of indicators
Open this folder and view contentsCHAPTER IV: Methodology for indicator calculation
Open this folder and view contentsCHAPTER V: Detailed presentation of indicators
Close this folderANNEX 1: Data collection forms
View the documentData Collection Form 1 - Private drug outlets
View the documentData Collection Form 2 - Public sector drug outlets
View the documentData Collection Form 3 - Health facilities/prescribers
View the documentData Collection Form 4 - Remote health facilities
View the documentSummary Form 1 - National drug policy background information
View the documentSummary Form 2 - National drug policy structural indicators
View the documentSummary Form 3 - National drug policy process indicators
View the documentSummary Form 4 - National drug policy outcome indicators
View the documentANNEX 2: Glossary
View the documentANNEX 3: Table of random numbers
View the documentBACK COVER
 

Summary Form 1 - National drug policy background information

* Do not forget to indicate the year for which the information is collected and the source.

1. Country information

Population data

BG1: Total population


BG2: Average annual growth of the population (%)


BG3: Percentage of the total population living in urban areas


BG4: Life expectancy (years)


Economic data

BG5: GNP per capita (US$)


BG6: Average annual rate of inflation (%)


2. Health information

Health status data

BG7: Infant mortality rate (per 1,000 live births)


BG8: Maternal mortality rate (per 100,000 live births)


BG9: Top five causes and rate of infant morbidity











BG10: Top five causes and rate of infant mortality











BG11:Top five causes and rate of adult morbidity











BG12:Top five causes and rate of adult mortality











Health system data

BG13: Total number of prescribers


BG14: Total public health budget


BG15: Total value of international aid for the health sector


BG16: Total health expenditure (public + households + international aid)


3. Drug sector information

Economic data

BG17: Total public drug expenditure


BG18: Total value of international aid for drugs (cash + kind)


BG19: Total drug expenditure (public + households + international aid)


BG20: Total value of local production (ex-factory price) sold in the country


BG21: Total value of drug imports (CIF)


BG22: Total value of drugs under generic name (CIF price for imported drugs and ex-factory price for locally produced drugs) sold in the country


Human resources

BG23: Total number of pharmacists


BG24: Total number of pharmacy technicians or other aides/assistants


Drug sector organization

BG25: Total number of drug manufacturing units in the country


BG26: Total number of wholesalers in the country


BG27: Total number of pharmacies and drug outlets in the public sector (including health facilities and hospitals that dispense drugs)


BG28: Total number of pharmacies and drug outlets in the private sector


BG29: Total number of private pharmacies and drug outlets in the three major urban areas

 

Number of drugs

BG30: Total number of registered drugs (in dosage forms and strengths)


BG31: Total number of drugs on the national essential drugs list (in INN)


to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014